
What We’re Reading: Accelerated Approval Questions; Trump Position on Abortion Ban; Therapists Raising Fees
There is discrepancy between the FDA’s accelerated approval decisions and clinical benefits in cancer treatments; former President Donald Trump’s video statement avoids a clear stance on national abortion legislation; 40% of therapists say they will increase their fees this year.
Limited Benefits of Cancer Drugs Granted Accelerated Approval
A recent study found that most cancer drugs granted accelerated approval by the FDA do not demonstrate significant clinical benefits within 5 years,
Trump Defers Abortion Decision to States
In a video posted to Truth Social, former President Donald Trump avoided endorsing federal abortion legislation, instead advocating for state-based decisions on the issue,
Four in 10 Therapists Plan to Raise Fees in 2024
A survey conducted by Heard revealed that 40% of therapists intend to increase their fees in 2024, with inflation and economic uncertainties being cited as contributing factors,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.